Cite
Jeannerat A, Peneveyre C, Armand F, et al. Hypoxic Incubation Conditions for Optimized Manufacture of Tenocyte-Based Active Pharmaceutical Ingredients of Homologous Standardized Transplant Products in Tendon Regenerative Medicine. Cells. 2021;10(11)doi: 10.3390/cells10112872.
Jeannerat, A., Peneveyre, C., Armand, F., Chiappe, D., Hamelin, R., Scaletta, C., Hirt-Burri, N., de Buys Roessingh, A., Raffoul, W., Applegate, L. A., & Laurent, A. (2021). Hypoxic Incubation Conditions for Optimized Manufacture of Tenocyte-Based Active Pharmaceutical Ingredients of Homologous Standardized Transplant Products in Tendon Regenerative Medicine. Cells, 10(11), . https://doi.org/10.3390/cells10112872
Jeannerat, Annick, et al. "Hypoxic Incubation Conditions for Optimized Manufacture of Tenocyte-Based Active Pharmaceutical Ingredients of Homologous Standardized Transplant Products in Tendon Regenerative Medicine." Cells vol. 10,11 (2021). doi: https://doi.org/10.3390/cells10112872
Jeannerat A, Peneveyre C, Armand F, Chiappe D, Hamelin R, Scaletta C, Hirt-Burri N, de Buys Roessingh A, Raffoul W, Applegate LA, Laurent A. Hypoxic Incubation Conditions for Optimized Manufacture of Tenocyte-Based Active Pharmaceutical Ingredients of Homologous Standardized Transplant Products in Tendon Regenerative Medicine. Cells. 2021 Oct 25;10(11). doi: 10.3390/cells10112872. PMID: 34831095; PMCID: PMC8616528.
Copy
Download .nbib